about
The myofibroblast: one function, multiple originsMetabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Advances in cholangiocyte immunobiologyPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsLiver fibrosisThe role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in miceMechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transitionRole of NADPH oxidases in liver fibrosis.Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling.Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver diseaseBile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.Hepatitis C virus virology and new treatment targets.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver.Establishment and characterization of rat portal myofibroblast cell lines.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CEvolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.Chronic restraint stress decreases the repair potential from mesenchymal stem cells on liver injury by inhibiting TGF-β1 generation.Wound healing in the biliary tree of liver allografts.Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.Liver fibrosis: searching for cell model answers.Effect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C.Bioconjugation of oligonucleotides for treating liver fibrosis.Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitisPortal fibroblasts: Underappreciated mediators of biliary fibrosis.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Transient elastography for assessment of fibrosis in paediatric liver disease.Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice.The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation.Early growth response factor-1 is critical for cholestatic liver injury.Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.Functional Immune Anatomy of the Liver-As an Allograft.Hepatic segmental atrophy and nodular elastosis: imaging features.Biochemical and histopathological study in rats intoxicated with carbontetrachloride and treated with camel milk.Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway.Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro.Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
P2860
Q24683749-0C640A90-1960-4158-8A65-38019B61358BQ26769611-1292C69D-BB49-40A7-9A96-432126672FA2Q27002954-7AE3E1FC-A215-4DA3-A425-3FDC996C1BE2Q28071596-10C0FFC5-D9F9-463B-AD3B-348C7926132BQ29547449-CBE7C9B8-1EFB-4867-A3B6-9702DEE4172CQ30613139-B733150C-E008-4C36-8C13-98E896971179Q33563882-0044365E-D26B-41DF-A2F8-67975292F5F4Q33632736-84DFD7EF-42EA-402A-958A-527584FC6C97Q33643380-5A6B7D25-395B-44C4-8FC7-8152860E1E20Q33866788-25AC45F8-24CB-4188-AC34-B56D6961A61BQ34760897-157BFD4B-E610-4D4D-BAB8-2A866D2E3F4FQ34974042-7F94D113-1D8E-43BA-8544-5D905EFF68E0Q34992341-BEAB0BA3-C404-40A3-B2FD-06E21D651E53Q35165731-35309C94-D267-4D88-9ED6-17542FF2A5FFQ35589905-2B071609-ED42-482D-A960-486870B82340Q35622533-E2C908ED-4D78-43DF-9416-D94B996431A7Q35649316-B7890C84-B989-43AE-A113-53B14C0DF8BAQ35810531-EC9B8FD6-6D7A-46AC-A08A-8A0740E0289CQ36014644-9D2B834C-6E43-4BC1-8709-7764A0FBC575Q36179620-344BD871-8D56-4723-BBD7-9879F5C90D82Q36529994-46AB07BE-5E04-4278-9107-F123D942E476Q36693626-D7C2136A-3E6F-40BB-8A90-76B4E4D4D8C6Q36777935-C1A50BC5-79AD-4C38-AAD1-C0CAFD41D895Q36853076-E8A761D0-4BD4-4C02-BA5F-3C897D9D9EC2Q37043515-6F0A9745-E544-4407-BE9F-4D0BC2E8499EQ37122480-54444BC0-6FB7-4EB7-AF5E-A27D354FFB76Q37704267-6BBA9A25-7D94-4690-A268-1A87C72FCCC0Q37800793-32465413-E411-4D5F-9AB8-877A15B44ED8Q37890296-392BE913-0764-43AD-B7BE-676267B69851Q38297119-56F701B9-6239-41CC-A924-0F7DF7391695Q38366288-D53205EE-2C3E-47A7-88F4-3E19D8F1A23CQ38511428-E8812EF9-1089-4704-A0A5-EBD59E18F66EQ38635618-BC19D6A1-3C3B-4AC3-842F-FCB7F96BC09CQ38723925-1371DBF0-D46C-44AC-B28D-B90166B5B88AQ39272653-7CDB8348-D1FB-41C8-8020-127FBFEEBEE9Q39452269-6563F618-86E6-436F-BCDF-0A0AD926B240Q39456788-C1FEBA94-7E5D-422D-8F3E-FB311AAE4690Q40059303-22E0DE44-6032-4EAA-B1F3-81613B174281Q40130232-14466817-E85B-40FF-B2C3-3555F3735E93Q40556586-E07C2C50-C61B-43E7-820E-A9C161A00F10
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Portal tract fibrogenesis in the liver.
@ast
Portal tract fibrogenesis in the liver.
@en
type
label
Portal tract fibrogenesis in the liver.
@ast
Portal tract fibrogenesis in the liver.
@en
prefLabel
Portal tract fibrogenesis in the liver.
@ast
Portal tract fibrogenesis in the liver.
@en
P2860
P1476
Portal tract fibrogenesis in the liver.
@en
P2093
Bernhard Saile
Giuliano Ramadori
P2860
P2888
P304
P356
10.1038/LABINVEST.3700030
P577
2004-02-01T00:00:00Z